Herzich Paul 4
4 · Solid Biosciences Inc. · Filed Feb 18, 2025
Insider Transaction Report
Form 4
Herzich Paul
Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-13+7,187→ 21,076 total - Sale
Common Stock
2025-02-14$3.96/sh−2,688$10,644→ 18,388 total - Exercise/Conversion
Restricted Stock Units
2025-02-13−7,187→ 21,563 total→ Common Stock (7,187 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock (the "RSUs").
- [F2]This sale was made to cover withholding taxes following the vesting of the previously granted RSUs pursuant to a durable automatic sales instruction letter adopted by Mr. Herzich on August 16, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Mr. Herzich.
- [F3]The RSUs were granted on February 13, 2024 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.